109145 ⎘
Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.
Mammal with an orthotopic tumor capable of metastasis, a method of making and a method of using
#6002METHODS AND COMPOSITIONS RELATED TO THE SMCHD1 GENE
#6003Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#6004Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
#6005Compositions and methods for controlling arthropod parasite and pest infestations
#6006Oligonucleotide compounds comprising non-nucleotide overhangs
#6007METHODS OF TREATING OBESITY
#6008Treatments of oxidative stress conditions
#6009Generation of human induced pluripotent stem cells using nucleic acid sequences that inhibit Δ-NP63 and DGCR8
#6010Skin lightening composition
#6011Method for expression of small RNA molecules within a cell
#6012Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1
#6013HEXIM-1 AS A TARGET OF LEPTIN SIGNALING TO REGULATE OBESITY AND DIABETES
#6014Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity
#6015Chemical modification of short small hairpin RNAs for inhibition of gene expression
#6016siRNA compounds comprising terminal substitutions
#6017THERAPIES FOR CANCER USING RLIP76
#6018Modulation of TLR4-signaling pathway
#6019Isoform of Bruton's Tyrosine Kinase (BTK) Protein
#6020AEROSOL DELIVERY SYSTEMS, COMPOSITIONS AND METHODS
#6021RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#6022NUCLEIC ACID COMPLEX AND NUCLEIC ACID-POLYSACCHARIDE COMPLEX
#6023Sugar chain-containing polymer, and sugar chain-containing polymer complex
#6024USP37 inactivation as a treatment for PLZF/RARA-associated acute promyelocytic leukemia
#6025Methods and compositions for inhibiting the growth and/or proliferation of MYC-driven tumor cells
#6026Constructs for diagnosing and treating inflammatory bowel diseases and colon cancer
#6027Compositions and methods for controlling leptinotarsa
#6028Ionizable cationic lipid for RNA delivery
#6029Charge conversional ternary polyplex
#6030RNA interference mediating small RNA molecules
#6031Therapeutic targets for Alzheimer's disease
#6032Methods of treating and diagnosing diseases using agents that regulate the alternative splicing pathway
#6033Small molecule inhibitors of RNA binding motif (RBM) proteins for the treatment of acute cellular injury
#6034Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
#6035Sustained release siRNA for ocular drug delivery
#6036Method of diagnosing, treating and determining progression and survival of cancer cells using BCL-2 antagonist of cell death (BAD) pathway gene signature
#6037Lipidated glycosaminoglycan particles for the delivery of nucleic acids
#6038METHODS FOR DIAGNOSING AND TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS
#6039COMPOSITIONS AND METHODS FOR THE TREATMENT OF RADIATION EXPOSURE
#6040USES OF CXCL17, A NOVEL CHEMOKINE MARKER OF HUMAN LUNG AND GASTROINTESTINAL DISEASE
#6041Methods and Uses for Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors
#6042Compositions and methods for the control of root lesion nematode
#6043Compositions for controlling mites in bees
#6044Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1
#6045PYRUVATE DEHYROGENASE KINASES AS THERAEUTIC TARGETS FOR CANCER AND ISCHEMIC DISEASES
#6046METHOD FOR DOWN-REGULATING GENE EXPRESSION IN FUNGI
#6047Compositions and methods for inducing myoblast differentiation and myotube formation
#6048Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide delivery
#6049High complexity siRNA pools
#6050Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications
#6051Composition and methods for reduced scarring and treatment of fibrosis
#6052METHODS OF MODULATING ANGIOGENESIS VIA TRPV4
#6053TREATMENT OF CANCER
#6054Transgenic plant-based methods for plant pests using RNAI
#6055Combination therapy for treating hearing and balance disorders
#6056Reducing galectin-12 activity to influence the cell function of human sebocytes
#6057Modulation of sphingosine 1-phosphate metabolizing enzymes for the treatment of negative-strand RNA virus infections
#6058Diagnosis of autism spectrum disorders and its treatment with an antagonist or inhibitor of the 5-HT2c receptor signaling pathway
#6059AMPK activator screening method, and AMPK activator
#6060Transferrin receptor aptamers and aptamer-targeted delivery
#6061COLON DISEASE TARGETS AND USES THEREOF
#6062Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8
#6063RNA products and uses thereof
#6064CUL4B as predictive biomarker for cancer treatment
#6065Influenza virus reassortment method
#6066Method for constructing functional nucleic acid molecule, and nucleic acid combination to be used in said method
#6067Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules
#6068Lipid nanoparticle compositions and methods of making and methods of using the same
#6069Methods and compositions for root knot nematode control
#6070Compositions and Methods for Inhibiting Expression of RRM2 Genes
#6071Method for treating glioma using Tarbp2 expression inhibitor
#6072Inhibition of DNA2 in fanconi anemia
#6073RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor
#6074Compositions and methods for decreasing leukocyte extravasation and vessel fluid leakage
#6075Compositions and methods for silencing ebola virus gene expression
#6076Compositions and methods for inhibiting expression of the ALAS1 gene
#6077Cancer therapeutics
#6078Composition for gene delivery
#6079Compositions and methods for siRNA inhibition of angiogenesis
#6080Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
#6081Interfering RNA molecules
#6082Polynucleotide comprising sequences of wheat gliadins and use thereof for silencing by RNAi
#6083Treatment of Paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1
#6084Multi-targeting short interfering RNAs
#6085MEANS AND METHODS FOR THE SPECIFIC MODULATION OF TARGET GENES IN THE CNS AND THE EYE AND METHODS FOR THEIR IDENTIFICATION
#6086Fidgetin-like 2 as a target to enhance wound healing
#6087RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
#6088Single-stranded nucleic acid molecule for regulating expression of gene having delivering function
#6089LIM kinasemodulating agents for neurofibromatoses therapy and methods for screening for same
#6090Compositions and methods for the treatment of VprBP-related cancers
#6091GNAQ targeted dsRNA compositions and methods for inhibiting expression
#6092Rational design of microRNA-siRNA chimeras for multi-functional target suppression
#6093COMPOSITIONS AND METHODS FOR MODULATING MITOCHONDRIAL PYRUVATE CARRIER ACTIVITY
#6094NOVEL THERAPEUTIC TARGET AND DIAGNOSTIC MARKER FOR ASTHMA AND RELATED CONDITIONS
#6095Methods of Treating Hepatitis C Virus Infection
#6096Method of regulating gene expression
#6097RNA-interference by single-stranded RNA molecules
#6098Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF
#6099Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFLD)
#6100METHOD FOR TREATING CELL PROLIFERATIVE DISORDER BY INHIBITING C1GALT1 EXPRESSION
#6101Block copolymer, liquid composite thereof, nucleic acid preparation, preparation methods therefor, and use thereof
#6102METHOD OF CONTROLLING INITIAL DRUG RELEASE OF siRNA FROM SUSTAINED-RELEASE IMPLANTS
#6103MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS
#6104Micro-RNAs involved in macular degeneration
#6105G protein-coupled purinergic receptor Gpr17 mediates orexigenic effects of FoxO1 in AgRP neurons
#6106COMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF siRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXES
#6107Lipid-derived neutral nanoparticles
#6108Cancer-related extracellular matrix signatures and related methods and products
#6109Glycaspis Brimblecombei Control Agents
#6110Bronze bug control agents
#6111MULTI-TARGET MODULATION FOR TREATING FIBROSIS AND INFLAMMATORY CONDITIONS
#6112Spalt-like transcription factor 4 (SALL4) and uses thereof
#6113Reduction of formation of amidated amino acids in cell lines for protein expression
#6114Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
#6115Method for treatment of diabetes by a small molecule inhibitor for GRK5
#6116Agents and methods for treating and preventing seborrheic keratosis
#6117ANTI-NEOPLASTIC USES OF ARTEMIN ANTAGONISTS
#6118iRNA agents with biocleavable tethers
#6119Micro-RMA inhibitor
#6120Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
#6121Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor
#6122DELIVERY MOLECULES FOR THERAPEUTICS
#6123NOVEL NTRK1 FUSION MOLECULES AND USES THEREOF
#6124Methods and pharmaceutical compositions for the treatment of hypertension
#6125BIOMARKERS FOR CANCER CHARACTERIZATION AND TREATMENT
#6126Methods for genome-wide screening and construction of genetic interaction maps
#6127Methods and kits for synthesis of siRNA expression cassettes
#6128RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules
#6129Use of annexin A3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
#6130LM-antibodies, functional fragments, LM-1 target antigen, and methods for making and using same
#6131Combination therapy using c-Met inhibitor and beta-catenin inhibitor
#6132EGFL7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis
#6133Compositions and methods for treating otitis media and other conditions with inhibitors of CYLD
#6134METHODS FOR DELIVERY OF siRNA TO THE SPINAL CORD AND THERAPIES ARISING THEREFROM
#6135Glycoconjugates of RNA interference agents
#6136Methods for controlling pests using RNAi
#6137THERAPEUTIC TARGETS FOR MITOCHONDRIAL DISORDERS
#6138Methods and compositions for the specific inhibition of MCL1 by double-stranded RNA
#6139Neurofibromatoses therapeutic agents and screening for same
#6140Methods of treating cancer having an active Wnt/β-catenin pathway
#6141Visfatin therapeutic agents for the treatment of acne and other conditions
#6142REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#6143METHOD FOR INHIBITING CELL GROWTH, NUCLEIC ACID MOLECULE HAVING RNA INTERFERENCE EFFECT ON NEK10 VARIANT GENE, AND ANTICANCER AGENT
#6144Trialkyl cationic lipids and methods of use thereof
#6145High molecular weight arginine-grafted bioreducible polymers
#6146Methods and compositions for the specific inhibition of KRAS by asymmetric double-stranded RNA
#6147RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA
#6148NOVEL FUSION GENES IDENTIFIED IN LUNG CANCER
#6149USE OF INHIBITORS OF ZDHHC2 ACTIVITY FOR MODULATION OF ADIPOGENESIS
#6150Double-stranded oligonucleotides
#6151Methods for the treatment of nonalcoholic steatohepatitis
#6152Cellular targets for HIV infection
#6153HIGH THROUGHPUT METHODS FOR FUNCTIONALLY DETERMINING RNA INTERFERENCE EFFICIENCY
#6154Methods of treating proliferative disorders with malate or derivatives thereof
#6155Compositions of combinations of non-covalent DNA binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment
#6156BRANCHED POLYMERS
#6157Compositions and methods for insecticidal control of stinkbugs
#6158Dually derivatized chitosan nanoparticles and methods of making and using the same
#6159INHIBITORS OF NOX4 EXPRESSION AND /OR NOX4 FUNCTION AND THEIR USE IN THE PREVENTION AND TREATMENT OF NERVE INJURY AND/OR NEUROPATHIC PAIN
#6160Reverse micelle system comprising nucleic acids and use thereof
#6161Methods and compositions for RNAi-based cancer treatment
#6162Methods for treating eye disorders
#6163Methods for diagnosing and treating neuroendocrine cancer
#6164Combination therapy for cancer using HSP27 inhibitor and EGFR tyrosine kinase inhibitors or anti-folates
#6165Delivery of dsRNA to arthropods
#6166RNA-directed DNA cleavage by the Cas9-crRNA complex
#6167RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Duchenne and Becker Muscular Dystrophy
#6168Pain treatment
#6169METHOD OF REGULATING CFTR EXPRESSION AND PROCESSING
#6170Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations
#6171Compositions and Methods for Diagnosing, Preventing and Treating Intracranial Aneurysms
#6172Method of enhancing the efficacy of anti-hepatocyte growth factor receptor breast cancer therapy by administering an inhibitor of mena
#6173Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis
#6174Compositions for Inhibiting Gene Expression and Uses Thereof
#6175Extended dicer substrate agents and methods for the specific inhibition of gene expression
#6176Extended dicer substrate agents and methods for the specific inhibition of gene expression
#6177Pharmaceutical composition for preventing or treating diabetes containing TENC1 expression or activity suppressor
#6178Nano delivery systems for siRNA
#6179siRNA compositions and methods for inhibiting gene expression in tumor initiating cells of breast cancer
#6180ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2
#6181RNA-Mediated Gene Modulation
#6182Anaplastic lymphoma kinase (ALK) as an oncogene capable of transforming normal human cells
#6183Modulating the interaction between ZO-2/TJP2 and a Snail zinc finger transcription factor family member
#6184Methods and compositions for neuroprotection
#6185Nanoconjugates able to cross the blood-brain barrier
#6186TREATMENT OF UTERINE LEIOMYOMATA
#6187RHOGEF12 IS A THERAPEUTIC TARGET FOR THE TREATMENT OF HEART FAILURE
#6188Vitamin B6-coupled poly(ester amine) as gene carrier and application in cancer gene therapy
#6189Increasing taxane sensitivity in cancer cells
#6190POLYPEPTIDES AND POLYNUCLEOTIDES FOR ARTEMIN AND RELATED LIGANDS, AND METHODS OF USE THEREOF
#6191BACTERIAL MEDIATED THF ALPHA GENE SILENCING
#6192Identification of molecular pathways and methods of use thereof for treating retinal neurodegeneration and other neurodegenerative disorders
#6193Compositions and methods for the suppression of target polynucleotides from lepidoptera
#6194Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro
#6195Aptamer regulated nucleic acids and uses thereof
#6196Pharmaceutical compositions for preventing or treating angiogenic diseases comprising inhibitors of NUP153 gene expression or NUP153 activity as active ingredient
#6197Compositions and methods for diagnosing and treating hyperthyroidism in companion animals
#6198Method for Preparing Fertility-Lowered Plant
#6199Compositions and methods for the modulation of DNA damage responses using BAL1 and BBAP
#6200CELL ADHESION INHIBITOR, CELL PROLIFERATION INHIBITOR, AND METHOD AND KIT FOR EXAMINING CANCER
#6201Double-stranded and single-stranded RNA molecules with 5′ Triphosphates and their use for inducing interferon
#6202Personalized medicine for the prediction of therapy targeting the hedgehog pathway
#6203Arginine-based lipids for delivery of therapeutics
#6204BACTERIAL MEDIATED THF ALPHA GENE SILENCING
#6205EMT-INDUCING TRANSCRIPTION FACTORS COOPERATE WITH SOX9
#6206NUCLEIC ACID MOLECULE FOR INHIBITING ACTIVITY OF RNAI MOLECULE
#6207METHODS AND COMPOSITIONS FOR TREATING INSECTS
#6208RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF
#6209Inhibition of the glycine cleavage system for treatment of cancer
#6210Method for enhancing remyelination using GLI1 inhibitors
#6211iRNA Agents Targeting VEGF
#6212Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
#6213Compositions and methods to promote erythropoiesis
#6214Single-Stranded Nucleic Acid Molecule for Controlling Gene Expression
#6215Methods, kits, and systems for treatment of metastatic papillary thyroid cancer
#6216Compositions and Methods for Suppressing Gene Expression of p53 and Clusterin
#6217Cottonseed oil and uses
#6218Use of human NLK gene and associated drugs thereof
#6219ADAM12 inhibitors and their use against inflammation-induced fibrosis
#6220High-efficiency nanoparticle-type double-helical oligo-RNA structure and method for preparing same
#6221Methods and compositions for reducing viral genome amounts in a target cell
#6222Lipid particle, nucleic acid transfer carrier, compound for manufacturing nucleic acid transfer carrier, method for manufacturing lipid particle, and gene transfer method
#6223Novel shRNA Molecules and Methods of Use Thereof
#6224Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#6225Methods and compositions involving miRNA and miRNA inhibitor molecules
#6226METHODS AND COMPOSITIONS FOR INCREASING RNA INTERFERENCE
#6227Simultaneous gene silencing and suppressing gene silencing in the same cell
#6228Transgenic plants modified for reduced cadmium transport, derivative products, and related methods
#6229Transcriptional repression leading to parkinson's disease
#6230INHIBITION OF PATTERN RECOGNITION RECEPTORS IN PANCREATIC CANCER TREATMENT USING TLR INHIBITORS
#6231Retinaldehyde mimetics and inhibitors of retinaldehyde dehydrogenase I in the treatment of disorders
#6232Collateral gene inactivation biomarkers and targets for cancer therapy
#6233DESIGN OF NUCLEIC ACID BINDING MOLECULES WITH NON-WATSON CRICK AND NON-CANONICAL PAIRING BASED ON ARTIFICIAL MUTATION CONSENSUS SEQUENCES TO COUNTER ESCAPE MUTATIONS
#6234MATERIALS AND METHODS FOR TREATING PTEN MUTATED OR DEFICIENT CANCER
#6235Agonists and antagonists of toll-like receptor (TLR) 13
#6236Treatment of vasculoproliferative conditions with Lrg1 antagonists
#6237Methods and compositions involving NKG2D inhibitors and cancer
#6238Polypeptides having beta-xylosidase activity and polynucleotides encoding same
#6239dsRNA as insect control agent
#6240Method to trigger RNA interference
#6241Double-stranded RNA compounds to CASP2 and uses thereof
#6242Prevention and treatment of Nosema disease in bees
#6243Methods and compositions to protect aquatic invertebrates from disease
#6244Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
#6245Amine cationic lipids and uses thereof
#6246RNA interference for the treatment of gain-of-function disorders
#6247INHIBITION OF MACROPHAGE-SYNTHESIZED WNT7B TO INHIBIT TUMOR ANGIOGENESIS AND METASTASIS
#6248Therapeutic nanoparticles and methods of use thereof
#6249Screening method
#6250Methods and compositions for the treatment of cancer
#6251COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS
#6252CDCP1 AND BREAST CANCER
#6253Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
#6254RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis
#6255RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
#6256RNAi-mediated inhibition of tumor necrosis factor α-related conditions
#6257Metabolic gene mesenchymal signatures and uses thereof
#6258RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
#6259Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier
#6260COMPOSITIONS AND METHODS FOR TREATMENT OF METASTATIC CANCER
#6261siRNA conjugate and preparation method thereof
#6262Methods and compositions involving miRNA and miRNA inhibitor molecules
#6263Peptide sequence design and use thereof for peptide-mediated siRNA delivery
#6264Small interference RNAs, uses thereof and method for inhibiting the expression of plk1 gene
#6265Amphipathic co-oligomers for the delivery of siRNA
#6266Compositions and methods for inhibiting expression of the PCSK9 gene
#6267Extended dicer substrate agents and methods for the specific inhibition of gene expression
#6268Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer
#6269Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity
#6270Serapina1 iRNA compositions and methods of use thereof
#6271RTP801L SIRNA COMPOUNDS AND METHODS OF USE THEREOF
#6272Feeder-free Derivation of human-induced pluripotent stem cells with synthetic messenger RNA
#6273IN VIVO DELIVERY OF NUCLEIC ACIDS TO THE LIVER OR LIVER TISSUE
#6274COMBINATORIAL METHODS AND COMPOSITIONS FOR TREATMENT OF MELANOMA
#6275RNAi for the control of insects and arachnids
#6276IN VIVO DELIVERY OF NUCLEIC ACIDS TO THE LIVER OR LIVER TISSUE
#6277Method of treating and reducing the risk of acute myelogenous leukemia
#6278RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (SINA)
#6279Oligonucleotides for RNA interference and biological applications thereof
#6280Method for reducing expression of downregulated in renal cell carcinoma in malignant gliomas
#6281Compositions and methods for inhibiting expression of factor VII gene
#6282METHODS AND COMPOSITIONS FOR REDUCING ACTIVITY OF THE ATRIAL NATRIURETIC PEPTIDE RECEPTOR AND FOR TREATMENT OF DISEASES
#6283Combined hairpin-antisense compositions and methods for modulating expression
#6284METHODS AND COMPOSITIONS TO MODULATE ANTIVIRAL AND IMMUNE ACTIVITY RESPONSES
#6285MCPIP as wound therapy
#6286siRNA molecule for inhibiting growth of melanin and application thereof
#6287Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#6288Lipid Formulated Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes
#6289Methods of identifying and using MDM2 inhibitors
#6290Therapeutic use of activators of zinc finger protein GL13
#6291Compositions and methods for modulating an immune response
#6292DELIVERY OF RNA INTERFERING AGENTS
#6293NOVEL DOUBLE-STRANDED RIBONUCLEIC ACIDS WITH RUGGED PHYSICO-CHEMICAL STRUCTURE AND HIGHLY SPECIFIC BIOLOGIC ACTIVITY
#6294Methods and pharmaceutical compositions for treating cancer
#6295Culicinae mosquito Tra-2 RNA interference technique to genetically produce maleness population
#6296Single-stranded nucleic acid molecule having amino acid backbone
#6297Lipids, lipid complexes and use thereof
#6298Oligomeric compounds and compositions for use in modulation of small non-coding RNAS
#6299Exonuclease resistant polynucleotide and related duplex polynucleotides, constructs, compositions, methods and systems
#6300Oligonucleotide modulators of the toll-like receptor pathway